Beta(2)-adrenergic receptor agonists increase intracellular free Ca(2+) concentration cycling in ventricular cardiomyocytes through p38 and p42/44 MAPK-mediated cytosolic phospholipase A(2) activation

J Biol Chem. 2001 Oct 26;276(43):39539-48. doi: 10.1074/jbc.M100954200. Epub 2001 Aug 15.

Abstract

We have recently reported that arachidonic acid mediates beta(2)-adrenergic receptor (AR) stimulation of [Ca(2+)](i) cycling and cell contraction in embryonic chick ventricular cardiomyocytes (Pavoine, C., Magne, S., Sauvadet, A., and Pecker, F. (1999) J. Biol. Chem. 274, 628-637). In the present work, we demonstrate that beta(2)-AR agonists trigger arachidonic acid release via translocation and activation of cytosolic phospholipase A(2) (cPLA(2)) and increase caffeine-releasable Ca(2+) pools from Fura-2-loaded cells. We also show that beta(2)-AR agonists trigger a rapid and dose-dependent phosphorylation of both p38 and p42/44 MAPKs. Translocation and activation of cPLA(2), as well as Ca(2+) accumulation in sarcoplasmic reticulum stores sensitive to caffeine and amplification of [Ca(2+)](i) cycling in response to beta(2)-AR agonists, were blocked by inhibitors of the p38 or p42/44 MAPK pathway (SB203580 and PD98059, respectively), suggesting a role of both MAPK subtypes in beta(2)-AR stimulation. In contrast, beta(1)-AR stimulation of [Ca(2+)](i) cycling was rather limited by the MAPKs, clearly proving the divergence between beta(2)-AR and beta(1)-AR signaling systems. This study presents the first evidence for the coupling of beta(2)-AR to cardiac cPLA(2) and points out the key role of the MAPK pathway in the intracellular signaling elicited by positive inotropic beta(2)-AR agonists in heart.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic alpha-Antagonists / pharmacology
  • Adrenergic beta-Agonists / pharmacology*
  • Animals
  • Caffeine / pharmacology
  • Calcium / metabolism*
  • Cell Compartmentation / drug effects
  • Cells, Cultured
  • Chick Embryo
  • Cytosol / enzymology
  • Drug Antagonism
  • Enzyme Activation
  • Ethanolamines / pharmacology
  • Heart Ventricles / cytology
  • Heart Ventricles / embryology
  • Heart Ventricles / metabolism*
  • Mitogen-Activated Protein Kinase 1 / metabolism
  • Mitogen-Activated Protein Kinase 3
  • Mitogen-Activated Protein Kinases / metabolism
  • Myocardium / cytology
  • Myocardium / metabolism*
  • Phospholipases A / metabolism
  • Protein Transport
  • Receptors, Adrenergic, beta-2 / drug effects*
  • Signal Transduction
  • p38 Mitogen-Activated Protein Kinases

Substances

  • Adrenergic alpha-Antagonists
  • Adrenergic beta-Agonists
  • Ethanolamines
  • Receptors, Adrenergic, beta-2
  • Caffeine
  • zinterol
  • Mitogen-Activated Protein Kinase 1
  • Mitogen-Activated Protein Kinase 3
  • Mitogen-Activated Protein Kinases
  • p38 Mitogen-Activated Protein Kinases
  • Phospholipases A
  • Calcium